Top

Published in:

01-06-2020 | Concise Research Report

Differences in Breast Density Awareness, Knowledge, and Plans Based on State Legislation Status and Sociodemographic Characteristics

Authors: Nancy R. Kressin, PhD, Jolie B. Wormwood, PhD, Tracy A. Battaglia, MD, MPH, Christine M. Gunn, PhD

Published in: Journal of General Internal Medicine | Issue 6/2020

Excerpt

State-level legislation requires informing women about breast density (BD) with mammogram results, to increase awareness of BD’s tendency to mask cancers on mammography, association with increased breast cancer risk, and encourage women to discuss personal risk and supplemental screening with physicians. The Food and Drug Administration is developing dense breast notification (DBN) language for use nationwide;¹ information about effects of state DBNs could be informative. …

Food and Drug Administration, H. Mammography Quality Standards Act. 2019; Available from: https://www.federalregister.gov/documents/2019/03/28/2019-05803/mammography-quality-standards-act.

Rhodes DJ, et al. Awareness of breast density and its impact on breast cancer detection and risk. J Clin Oncol. 2015;33(10):1143–1150.CrossRef

Manning M, et al. Influences of race and breast density on related cognitive and emotion outcomes before mandated breast density notification. Soc Sci Med. 2016;169:171–179.CrossRef

Gunn C, et al. Women’s Perceptions of Dense Breast Notifications: “So what is that supposed to mean?”. Patient Educ Couns. 2018;101(6):1123–1129.CrossRef

Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. J Am Coll Radiol. 2019;16(2):139–146.CrossRef

Kressin NR, Gunn CM, Battaglia TA. Content, Readability, and Understandability of Dense Breast Notifications by State. Jama. 2016;315(16):1786–1788.CrossRef

Title: Differences in Breast Density Awareness, Knowledge, and Plans Based on State Legislation Status and Sociodemographic Characteristics
Authors: Nancy R. Kressin, PhD
Jolie B. Wormwood, PhD
Tracy A. Battaglia, MD, MPH
Christine M. Gunn, PhD
Publication date: 01-06-2020
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 6/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05578-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Differences in Breast Density Awareness, Knowledge, and Plans Based on State Legislation Status and Sociodemographic Characteristics

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2020

Components of the Patient-Centered Medical Home Associated with Perceived Access to Primary Care

Gender Equity in Leadership: SGIM, It’s Our Problem!

Coccidioidomycosis Presenting with Fever and Back Pain

Thiazide Diuretic–Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

Understanding the Workflow of Home Health Care for Patients with Heart Failure: Challenges and Opportunities

Social Determinants and Military Veterans’ Suicide Ideation and Attempt: a Cross-sectional Analysis of Electronic Health Record Data

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page